Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 25, 2019
Boston Scientific Corporation (NYSE: BSX) announced its completed public offering of senior notes.
-
Feb 21, 2019
Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of senior notes.
-
Feb 6, 2019
"Meaningful innovation and focused execution helped us deliver strong financial results in 2018," said CEO Mike Mahoney.
-
Jan 25, 2019
Rezūm patients experienced significant and sustained improvement in benign prostatic hyperplasia (BPH) symptoms and quality of life.
-
Jan 24, 2019Advanced systems offer customizable therapy addressing progression of Parkinson's disease
Advanced systems offer customizable therapy to treat Parkinson's symptoms.
-
Jan 22, 2019Results from the VIRTUS Study Show Venous Stent Met Its Primary Effectiveness and Safety Endpoints in Re-establishing Blood Flow at Twelve Months
Boston Scientific venous stent met VIRTUS trial primary effectiveness and safety endpoints in re-establishing blood flow.
-
Jan 8, 2019
Boston Scientific will webcast its conference call with financial results and business highlights for Q4 2018 and the full 2018 year.
-
Dec 27, 2018Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system
Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system
-
Dec 11, 2018Delaware Court Rules Edwards Lifesciences Infringes Boston Scientific Patent
Delaware court rules Edwards Lifesciences Infringes Boston Scientific patent
-
Nov 20, 2018Transaction would expand peripheral interventions portfolio with minimally-invasive treatments for cancers and vascular conditions
Transaction would expand Boston Scientific peripheral interventions portfolio with minimally invasive treatments for cancers and vascular conditions